Zhejiang Dian Diagnostics, one of China’s largest chains of independent medical laboratories, has entered into a joint laboratory licensing agreement with Metabolon, a metabolomics company based in North Carolina. Under the terms of the agreement, Dian will install Metabolon’s proprietary Discovery HD4™ platform in its new, state-of-the-art laboratory in Hangzhou and use its extensive market presence to commercialize Metabolon’s metabolomics-based products and services throughout China. Financial and other terms of the agreement were not disclosed.
